Anti-HBV Recombinant Antibody (Libivirumab) (CAT#: TAB-147)

Recombinant monoclonal antibody to HBV. Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-HBV Recombinant Antibody (TAB-147) in SDS-PAGE

Figure 1 Anti-HBV Recombinant Antibody (TAB-147) in SDS-PAGE

Lane 1: 1 μg, Non-Reducing Lane 2: 2 μg, Reducing


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native HBV antigen.
  • Species Reactivity
  • HBV
  • Applications
  • Suitable for use in WB, ELISA, IP, FC, FuncS, Neut, IF and most other immunological methods.
  • CAS
  • 569658-79-3
  • Generic Name
  • Libivirumab
  • MW
  • 149.04 kDa
  • Related Disease
  • Hepatitis B reinfection in liver transplant patients

Product Property

  • Purity
  • >95%, by SDS-PAGE with silver staining, under reducing conditions.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Target

  • Alternative Names
  • Libivirumab;569658-79-3;17.1.41;HBsAg;Hep B surface antigen;Hepatitis B Virus major surface antigen;Hepatitis B virus S antigen;Large envelope protein;Large surface protein;LHB;Major surface antigen

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Libivirumab"

Afuco™ Anti-HBV Surface Antigen ADCC Recombinant Antibody (Libivirumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to HBV. Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.

See other products for "HBV surface antigen"

Single-domain Antibody

CAT Product Name Application Type
NAB-1250-sdAb Recombinant Anti-HBV surface antigen VHH Single Domain Antibody WB, ICC, ChiP, FA, ELISA Llama VHH

Epitope-Specific Antibody

CAT Product Name Application Type
EPAF-0339CQ Recombinant Mouse Anti-HBV Surface antigen Antibody (MA 18/7) Inhib IgG1

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-147 Afuco™ Anti-HBV Surface Antigen ADCC Recombinant Antibody (Libivirumab), ADCC Enhanced FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody

Recombinant Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-147. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare